307 related articles for article (PubMed ID: 24163322)
1. Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy.
Bingham AL; Brown RO; Dickerson RN
Nutr Clin Pract; 2013 Dec; 28(6):766-9. PubMed ID: 24163322
[TBL] [Abstract][Full Text] [Related]
2. A potential interaction between warfarin and atovaquone.
Hidalgo K; Lyles A; Dean SR
Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
[TBL] [Abstract][Full Text] [Related]
4. Supratherapeutic international normalized ratio due to reduced vitamin K intake secondary to prolonged vomiting in a patient on warfarin.
Reaves AB; Clarke CJ; Tillman EM
Ann Pharmacother; 2013 Jun; 47(6):e28. PubMed ID: 23719786
[TBL] [Abstract][Full Text] [Related]
5. Interaction between gemfibrozil and warfarin: case report and review of the literature.
Dixon DL; Williams VG
Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
[TBL] [Abstract][Full Text] [Related]
6. Probable interaction between warfarin and marijuana smoking.
Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
[TBL] [Abstract][Full Text] [Related]
7. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
Christopher A
Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
[TBL] [Abstract][Full Text] [Related]
8. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
[TBL] [Abstract][Full Text] [Related]
9. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
Parrish RH; Pazdur DE; O'donnell PJ
Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
[TBL] [Abstract][Full Text] [Related]
11. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
Knudsen JF; Sokol GH
Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide and warfarin interaction: case report and review of the literature.
Chonlahan J; Halloran MA; Hammonds A
Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
[TBL] [Abstract][Full Text] [Related]
13. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate.
DuPont HL; Ericsson CD; Johnson PC; Bitsura JA; DuPont MW; de la Cabada FJ
JAMA; 1987 Mar; 257(10):1347-50. PubMed ID: 3820443
[TBL] [Abstract][Full Text] [Related]
14. Successful anticoagulation and continuation of tramadol therapy in the setting of a tramadol-warfarin interaction.
Dumo PA; Kielbasa LA
Pharmacotherapy; 2006 Nov; 26(11):1654-7. PubMed ID: 17064212
[TBL] [Abstract][Full Text] [Related]
15. Prevention of diarrhea caused by enterotoxigenic Escherichia coli: lessons learned with volunteers.
Graham DY; Evans DG
Rev Infect Dis; 1990; 12 Suppl 1():S68-72. PubMed ID: 2406859
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
Graham DY; Estes MK; Gentry LO
Gastroenterology; 1983 Nov; 85(5):1017-22. PubMed ID: 6352386
[TBL] [Abstract][Full Text] [Related]
17. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea.
Johnson PC; Ericsson CD; DuPont HL; Morgan DR; Bitsura JA; Wood LV
JAMA; 1986 Feb; 255(6):757-60. PubMed ID: 3944976
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
Mathews S; Cole J; Ryono RA
Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
[TBL] [Abstract][Full Text] [Related]
19. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
Liedtke MD; Vanguri A; Rathbun RC
Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
[TBL] [Abstract][Full Text] [Related]
20. Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.
Koulinska I; Riester K; Chalkias S; Edwards MR
Clin Ther; 2018 Dec; 40(12):2021-2030.e1. PubMed ID: 30447891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
